Not all individuals with CLL need therapy. Inspite of all the latest improvements, the iwCLL continue to endorses watchful observation for patients with asymptomatic condition.86 This suggestion is predicated on at least two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both of those https://jonathand197bks5.activablog.com/profile